{"transactions":[{"id":723806,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2026-06-29T22:00:42.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":15532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on June 25, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on June 25, 2027."}],"balance_after":15532,"derivative":{"underlying":"Common Stock","underlying_shares":15532},"source":{"system":"sec-edgar","filing":"0001365493-26-000008","document":"wk-form4_1782770440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000136549326000008/wk-form4_1782770440.xml","form_type":"4"}},{"id":747609,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T21:13:25.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":5368,"derivative":{"exercise_price":15.74,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":5368},"source":{"system":"sec-edgar","filing":"0001628280-26-041324","document":"wk-form4_1780694002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162828026041324/wk-form4_1780694002.xml","form_type":"4"}},{"id":747608,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:13:25.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":2890,"source":{"system":"sec-edgar","filing":"0001628280-26-041324","document":"wk-form4_1780694002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162828026041324/wk-form4_1780694002.xml","form_type":"4"}},{"id":754246,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2026-06-02T20:08:54.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 29, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001365493-26-000005","document":"wk-form4_1780430930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000136549326000005/wk-form4_1780430930.xml","form_type":"4"}},{"id":754245,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:08:54.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":9352,"source":{"system":"sec-edgar","filing":"0001365493-26-000005","document":"wk-form4_1780430930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000136549326000005/wk-form4_1780430930.xml","form_type":"4"}},{"id":767580,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:36:45.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an annual equity grant of Restricted Stock Units (\"RSUs\") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis."}],"balance_after":82105,"source":{"system":"sec-edgar","filing":"0001365493-26-000003","document":"wk-form4_1779395802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000136549326000003/wk-form4_1779395802.xml","form_type":"4"}},{"id":1112992,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:54:54.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":14370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an annual equity grant of Restricted Stock Units (\"RSUs\") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis."}],"balance_after":69520,"source":{"system":"sec-edgar","filing":"0001628280-25-031060","document":"wk-form4_1749761687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162828025031060/wk-form4_1749761687.xml","form_type":"4"}},{"id":1117532,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T21:26:04.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":8745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":8745,"derivative":{"exercise_price":13.15,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":8745},"source":{"system":"sec-edgar","filing":"0001415889-25-016327","document":"form4-06092025_050608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000141588925016327/form4-06092025_050608.xml","form_type":"4"}},{"id":1127314,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-06-02T20:23:22.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."}],"balance_after":6829,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001906324-25-000127","document":"wk-form4_1748895794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000190632425000127/wk-form4_1748895794.xml","form_type":"4"}},{"id":1133094,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-05-27T20:21:13.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":2523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 22, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2523},"source":{"system":"sec-edgar","filing":"0001906324-25-000095","document":"wk-form4_1748377266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000190632425000095/wk-form4_1748377266.xml","form_type":"4"}},{"id":1133093,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T20:21:13.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":2523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 3."}],"balance_after":2523,"source":{"system":"sec-edgar","filing":"0001906324-25-000095","document":"wk-form4_1748377266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000190632425000095/wk-form4_1748377266.xml","form_type":"4"}},{"id":1306416,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T21:57:11.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":15507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in thirty six (36) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":15507,"derivative":{"exercise_price":11.93,"expiration_date":"2035-01-05","underlying":"Common Stock","underlying_shares":15507},"source":{"system":"sec-edgar","filing":"0001415889-25-001147","document":"form4-01082025_090108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000141588925001147/form4-01082025_090108.xml","form_type":"4"}},{"id":1481797,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-06-12T21:02:10.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Huennekens' continued service through the applicable vesting date."}],"balance_after":79200,"derivative":{"exercise_price":0.87,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":79200},"source":{"system":"sec-edgar","filing":"0001209191-24-005848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919124005848/doc4.xml","form_type":"4"}},{"id":1503360,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:33:08.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":14170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an annual equity grant of Restricted Stock Units (\"RSUs\") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis."}],"balance_after":55150,"source":{"system":"sec-edgar","filing":"0001757073-24-000051","document":"wk-form4_1716496365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000175707324000051/wk-form4_1716496365.xml","form_type":"4"}},{"id":1789634,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:52:29.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-048184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048184/doc4.xml","form_type":"4"}},{"id":1789633,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:52:29.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-23-048184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048184/doc4.xml","form_type":"4"}},{"id":1789632,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:52:29.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-23-048184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048184/doc4.xml","form_type":"4"}},{"id":1789631,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:52:29.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3095},"source":{"system":"sec-edgar","filing":"0001209191-23-048184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048184/doc4.xml","form_type":"4"}},{"id":1789630,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:52:29.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2577},"source":{"system":"sec-edgar","filing":"0001209191-23-048184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048184/doc4.xml","form_type":"4"}},{"id":1789629,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-09-05T16:52:29.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the \"Effective Time\"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus  (\"Globus Class A Common Stock\"), par value $0.001 per share (the \"Exchange Ratio\" and such shares, the \"Merger Consideration\"), and cash in lieu of fractional shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-048184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048184/doc4.xml","form_type":"4"}},{"id":1853998,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"FORM 4","published_at":"2023-06-15T22:07:19.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":25480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Stock Options (Right to Buy)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each annual stock option (\"the Annual Option\") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, fi on such date the Reporting Person has remained in continuous service as director."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Common Stock"}],"balance_after":25480,"derivative":{"exercise_price":0.8349,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"FORM 4","underlying_shares":25480},"source":{"system":"sec-edgar","filing":"0001628280-23-022326","document":"wf-form4_168686682476075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162828023022326/wf-form4_168686682476075.xml","form_type":"4"}},{"id":1853997,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"FORM 4","published_at":"2023-06-15T22:07:19.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Stock"},{"field":"shares","element":"transactionShares","label":"F2","text":"Each annual restricted stock unit (\"Annual RSU\") will be scheduled to vest as to all of the Shares of Common Stock (\"Shares) subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting Person has remained in continuous service as a director."}],"balance_after":21840,"source":{"system":"sec-edgar","filing":"0001628280-23-022326","document":"wf-form4_168686682476075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162828023022326/wf-form4_168686682476075.xml","form_type":"4"}},{"id":1858466,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T20:30:25.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":237437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest 100% on June 9, 2028, subject to Mr. Huennekens' continued service through the vesting date."}],"balance_after":237437,"derivative":{"exercise_price":1.97,"expiration_date":"2033-06-09","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-23-036328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919123036328/doc4.xml","form_type":"4"}},{"id":1858465,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-12T20:30:25.000Z","date":"2023-06-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":237437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 9, 2023, Mr. Huennekens was granted a new stock option to purchase 237,437 shares of the Issuer's Class A common stock reported below that was contingent upon the cancellation of this stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."}],"balance_after":0,"derivative":{"exercise_price":0.91,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-23-036328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919123036328/doc4.xml","form_type":"4"}},{"id":1858464,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-12T20:30:25.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Huennekens' continued service through the applicable vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.97,"expiration_date":"2033-06-09","underlying":"Class A Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001209191-23-036328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919123036328/doc4.xml","form_type":"4"}},{"id":1859239,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2023-06-12T17:52:04.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."}],"balance_after":4816,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-036453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123036453/doc4.xml","form_type":"4"}},{"id":1877753,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T20:34:19.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":7625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an annual equity grant of Restricted Stock Units (\"RSUs\") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in sharesof common stock on a one-to-one basis."}],"balance_after":40980,"source":{"system":"sec-edgar","filing":"0001757073-23-000044","document":"wf-form4_168504684010744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000175707323000044/wf-form4_168504684010744.xml","form_type":"4"}},{"id":2128306,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."}],"balance_after":237437,"derivative":{"exercise_price":0.91,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128305,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"disposition_to_issuer","acquired":false,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."}],"balance_after":0,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128304,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted."}],"balance_after":237437,"derivative":{"exercise_price":0.91,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128303,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"disposition_to_issuer","acquired":false,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 as adjusted."}],"balance_after":0,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128302,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":712312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date."}],"balance_after":712312,"derivative":{"exercise_price":0.91,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":712312},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128301,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"disposition_to_issuer","acquired":false,"shares":712312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 222,595 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Huennekens' continued service on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":712312},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128300,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."}],"balance_after":237437,"derivative":{"exercise_price":0.91,"expiration_date":"2032-03-29","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2128299,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:53:58.000Z","date":"2022-10-31","kind":"disposition_to_issuer","acquired":false,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 29, 2022. The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.32,"expiration_date":"2032-03-29","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001209191-22-055106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122055106/doc4.xml","form_type":"4"}},{"id":2139046,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-11T21:01:52.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":5880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each annual stock option (the \"Annual Option\") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the Reporting Person has remained in continuous service as a director."}],"balance_after":5880,"derivative":{"exercise_price":0.88,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":5880},"source":{"system":"sec-edgar","filing":"0000950103-22-017614","document":"dp182284_4-huennekens.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010322017614/dp182284_4-huennekens.xml","form_type":"4"}},{"id":2139045,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-11T21:01:52.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each annual restricted stock unit (\"Annual RSU\") will be scheduled to vest as to all of the shares of Common Stock (\"Shares\") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting Person has remained in continuous service as a director."}],"balance_after":10920,"source":{"system":"sec-edgar","filing":"0000950103-22-017614","document":"dp182284_4-huennekens.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010322017614/dp182284_4-huennekens.xml","form_type":"4"}},{"id":2225056,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-21T21:43:36.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each annual stock option (the \"Annual Option\") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the Reporting Person has remained in continuous service as a director."}],"balance_after":19600,"derivative":{"exercise_price":0.5036,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0000950103-22-010954","document":"dp175622_4-huennekens.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010322010954/dp175622_4-huennekens.xml","form_type":"4"}},{"id":2225055,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:43:36.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each annual restricted stock unit (\"Annual RSU\") will be scheduled to vest as to all of the shares of Common Stock (\"Shares\") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting Person has remained in continuous service as a director."}],"balance_after":8400,"source":{"system":"sec-edgar","filing":"0000950103-22-010954","document":"dp175622_4-huennekens.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010322010954/dp175622_4-huennekens.xml","form_type":"4"}},{"id":2233780,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-13T20:08:41.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":85345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Huenneken's continued service through the applicable vesting date."}],"balance_after":85345,"derivative":{"exercise_price":2.2,"expiration_date":"2032-06-09","underlying":"Class A Common Stock","underlying_shares":85345},"source":{"system":"sec-edgar","filing":"0001209191-22-036275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919122036275/doc4.xml","form_type":"4"}},{"id":2243953,"issuer":{"id":83848,"kind":"organization","name":"Acutus Medical, Inc.","symbol":"AFIB"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T23:35:44.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":60000,"price":0.58,"value":34800.0,"ownership":{"direct":false,"nature":"By Front Foot Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were transferred by the reporting person to Front Foot Trust on March 10, 2022. The reporting person and Deborah Legome Huennekens are co-trustees of Front Foot Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.5800 to $0.6215 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of securities sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":507509,"source":{"system":"sec-edgar","filing":"0000950103-22-010124","document":"dp174786_4-huennekens.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010322010124/dp174786_4-huennekens.xml","form_type":"4"}},{"id":2250991,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:33:17.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":5930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an annual equity grant of Restricted Stock Units (\"RSUs\") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in sharesof common stock on a one-to-one basis."}],"balance_after":33355,"source":{"system":"sec-edgar","filing":"0001757073-22-000078","document":"wf-form4_165402916949843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000175707322000078/wf-form4_165402916949843.xml","form_type":"4"}},{"id":2272333,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-05-13T17:52:37.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3788,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-22-028938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122028938/doc4.xml","form_type":"4"}},{"id":2312615,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-31T22:09:11.000Z","date":"2022-03-29","kind":"grant","acquired":true,"shares":237437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on March 29, 2027, subject to Mr. Huenneken's continued service through the vesting date."}],"balance_after":237437,"derivative":{"exercise_price":3.32,"exercise_date":"2027-03-29","expiration_date":"2032-03-29","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001104659-22-041203","document":"tm2211004-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465922041203/tm2211004-6_4seq1.xml","form_type":"4"}},{"id":2438728,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T02:41:45.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in connection with the Mergers in exchange for a stock option to acquire 725,000 shares of Hyperfine common stock for $1.07 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."}],"balance_after":237437,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001104659-22-002889","document":"tm222483-4_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465922002889/tm222483-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-12-23"}},{"id":2438727,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T02:41:45.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in connection with the Mergers in exchange for a stock option to acquire 725,000 shares of Hyperfine common stock for $1.07 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\")"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 (as adjusted) within three years of the closing of the IPO; or (3) the closing of a private financing round within three years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 1.5 times $3.92 (as adjusted)."}],"balance_after":237437,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001104659-22-002889","document":"tm222483-4_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465922002889/tm222483-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-12-23"}},{"id":2438726,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T02:41:45.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":712312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. (\"HealthCor\"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor (\"Merger Sub I\"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor (\"Merger Sub II\"), Hyperfine, Inc., a Delaware corporation (\"Hyperfine\"), and Liminal Sciences, Inc., a Delaware corporation (\"Liminal\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"pursuant to which Merger Sub I merged with and into Hyperfine (the \"Hyperfine Merger\"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the \"Liminal Merger\" and, together with the Hyperfine Merger, the \"Mergers\"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to \"Hyperfine, Inc.\", the \"Issuer\"), these shares were received in connection with the Mergers in exchange for a stock option to acquire 2,175,000 shares of Hyperfine common stock for $1.07 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as to 25% on June 30, 2022, with the remainder of the options vesting in equal monthly installments over the following 36 months, subject to Mr. Huennekens' continued service on each vesting date."}],"balance_after":712312,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":712312},"source":{"system":"sec-edgar","filing":"0001104659-22-002889","document":"tm222483-4_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465922002889/tm222483-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-12-23"}},{"id":2438725,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-11T02:41:45.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":19586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Mr. Huennekens' continued service through the applicable vesting date."}],"balance_after":19586,"source":{"system":"sec-edgar","filing":"0001104659-22-002889","document":"tm222483-4_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465922002889/tm222483-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-12-23"}},{"id":2459387,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-24T02:42:06.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in connection with the Mergers in exchange for a stock option to acquire 725,000 shares of Hyperfine common stock for $1.07 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted)."}],"balance_after":237437,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001104659-21-153332","document":"tm2135698-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465921153332/tm2135698-15_4seq1.xml","form_type":"4"}},{"id":2459386,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-24T02:42:06.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":237437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in connection with the Mergers in exchange for a stock option to acquire 725,000 shares of Hyperfine common stock for $1.07 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Hyperfine and Liminal becoming a publicly traded company (a \"SPAC transaction\") within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Hyperfine and Liminal (\"IPO\")"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 (as adjusted) within three years of the closing of the IPO; or (3) the closing of a private financing round within three years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 1.5 times $3.92 (as adjusted)."}],"balance_after":237437,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001104659-21-153332","document":"tm2135698-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465921153332/tm2135698-15_4seq1.xml","form_type":"4"}},{"id":2459385,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-24T02:42:06.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":712312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. (\"HealthCor\"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor (\"Merger Sub I\"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor (\"Merger Sub II\"), Hyperfine, Inc., a Delaware corporation (\"Hyperfine\"), and Liminal Sciences, Inc., a Delaware corporation (\"Liminal\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"pursuant to which Merger Sub I merged with and into Hyperfine (the \"Hyperfine Merger\"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the \"Liminal Merger\" and, together with the Hyperfine Merger, the \"Mergers\"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to \"Hyperfine, Inc.\", the \"Issuer\"), these shares were received in connection with the Mergers in exchange for a stock option to acquire 2,175,000 shares of Hyperfine common stock for $1.07 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as to 25% on June 30, 2022, with the remainder of the options vesting in equal monthly installments over the following 36 months, subject to Mr. Huennekens' continued service on each vesting date."}],"balance_after":712312,"derivative":{"exercise_price":3.27,"expiration_date":"2031-04-27","underlying":"Class A Common Stock","underlying_shares":712312},"source":{"system":"sec-edgar","filing":"0001104659-21-153332","document":"tm2135698-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465921153332/tm2135698-15_4seq1.xml","form_type":"4"}},{"id":2459384,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-24T02:42:06.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":16483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Mr. Huennekens' continued service through the applicable vesting date."}],"balance_after":16483,"source":{"system":"sec-edgar","filing":"0001104659-21-153332","document":"tm2135698-15_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000110465921153332/tm2135698-15_4seq1.xml","form_type":"4"}},{"id":2692806,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:51:39.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":5455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an annual equity grant of Restricted Stock Units (\"RSUs\") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the date of the Issuer's 2022 Annual Meeting of Stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. RSUs are payable in shares of common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,970 RSUs that were previously reported in Table II."}],"balance_after":27425,"source":{"system":"sec-edgar","filing":"0001757073-21-000082","document":"wf-form4_162214865673410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000175707321000082/wf-form4_162214865673410.xml","form_type":"4"}},{"id":2703557,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2021-05-20T17:50:08.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2702,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-21-034547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121034547/doc4.xml","form_type":"4"}},{"id":3106558,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-17T22:08:18.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":52752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on June 15, 2021, subject to the Reporting Person remaining a service provider through such date."}],"balance_after":99670,"source":{"system":"sec-edgar","filing":"0001209191-20-037383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919120037383/doc4.xml","form_type":"4"}},{"id":3130286,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-29T20:24:32.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":11170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units are payable in shares of common stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units granted will vest on the date of the Issuer's 2021 annual meeting of stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the issuer."}],"balance_after":11170,"derivative":{"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":11170},"source":{"system":"sec-edgar","filing":"0001415889-20-001375","document":"form4-05292020_010519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000141588920001375/form4-05292020_010519.xml","form_type":"4"}},{"id":3130881,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2020-05-29T17:51:03.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":3095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will\nvest in full on the first to occur of (1) Issuer's 2021 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant.\nSettlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will\nvest in full on the first to occur of (1) Issuer's 2021 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant.\nSettlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3095,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3095},"source":{"system":"sec-edgar","filing":"0001209191-20-033001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919120033001/doc4.xml","form_type":"4"}},{"id":3317630,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T23:08:52.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":12707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on June 12, 2020, subject to the Reporting Person remaining a service provider through such date."}],"balance_after":46918,"source":{"system":"sec-edgar","filing":"0001209191-20-002088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000120919120002088/doc4.xml","form_type":"4"}},{"id":3531765,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2019-05-10T17:47:20.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will\nvest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant.\nSettlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will\nvest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant.\nSettlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2577,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2577},"source":{"system":"sec-edgar","filing":"0001209191-19-029058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919119029058/doc4.xml","form_type":"4"}},{"id":3531764,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2019-05-10T17:47:20.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":1360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on October 1, 2018 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on October 1, 2018 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1360},"source":{"system":"sec-edgar","filing":"0001209191-19-029058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919119029058/doc4.xml","form_type":"4"}},{"id":3531763,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T17:47:20.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":1360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to Company equity awards as disclosed on this Form 4."}],"balance_after":1360,"source":{"system":"sec-edgar","filing":"0001209191-19-029058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919119029058/doc4.xml","form_type":"4"}},{"id":3707700,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T01:18:30.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":18668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date."}],"balance_after":34211,"source":{"system":"sec-edgar","filing":"0000950103-19-000199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010319000199/ownership.xml","form_type":"4"}},{"id":3707699,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T01:18:30.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":9740,"price":6.16,"value":59998.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $60,000."}],"balance_after":15543,"source":{"system":"sec-edgar","filing":"0000950103-19-000199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010319000199/ownership.xml","form_type":"4"}},{"id":3718808,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-27T02:46:24.000Z","date":"2018-12-21","kind":"grant","acquired":true,"shares":32547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option had vested and were exercisable as of December 2018."}],"balance_after":32547,"derivative":{"exercise_price":5.21,"expiration_date":"2028-12-21","underlying":"Common Stock","underlying_shares":32547},"source":{"system":"sec-edgar","filing":"0000950103-18-015065","document":"dp100063_4-huennekens.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010318015065/dp100063_4-huennekens.xml","form_type":"4"}},{"id":3799064,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-10-03T17:58:49.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":1360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the date of the Issuer's 2019 Annual Meeting of Stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the date of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":1360,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1360},"source":{"system":"sec-edgar","filing":"0001209191-18-054044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118054044/doc4.xml","form_type":"4"}},{"id":3852868,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-03T21:01:07.000Z","date":"2018-08-02","kind":"grant","acquired":true,"shares":1941,"price":8.18,"value":15877.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued to the reporting person pursuant to ViewRay, Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $15,879."}],"balance_after":5803,"source":{"system":"sec-edgar","filing":"0000950103-18-009417","document":"dp94313_4-huennekens.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010318009417/dp94313_4-huennekens.xml","form_type":"4"}},{"id":3872339,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T21:44:42.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":3862,"price":7.12,"value":27497.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1/6th of these shares shall vest and become exercisable on the last day of each calendar month beginning on July 31, 2018, such that 100% of the shares will be vested on December 31, 2018, subject to the Reporting Person remaining a service provider through each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were issued to the reporting person pursuant to ViewRay, Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $27,500."}],"balance_after":3862,"source":{"system":"sec-edgar","filing":"0000950103-18-008368","document":"dp93191_4-huennekens.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010318008368/dp93191_4-huennekens.xml","form_type":"4"}},{"id":4014059,"issuer":{"id":111118,"kind":"organization","name":"ViewRay, Inc.","symbol":"VRAY"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-06T02:37:40.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":38622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option shall vest and become exercisable on each monthly anniversary measured from March 1, 2018 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each such vesting date."}],"balance_after":38622,"derivative":{"exercise_price":7.84,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":38622},"source":{"system":"sec-edgar","filing":"0000950103-18-003005","document":"dp87796_4-huennekens.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000095010318003005/dp87796_4-huennekens.xml","form_type":"4"}},{"id":4259063,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to  Buy)","published_at":"2017-07-11T20:15:41.000Z","date":"2017-07-09","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest in four equal quarterly installments, with the first installment on October 9, 2017."}],"balance_after":10500,"derivative":{"exercise_price":6.45,"expiration_date":"2027-07-09","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-17-044827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117044827/doc4.xml","form_type":"4"}},{"id":4259062,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-11T20:15:41.000Z","date":"2017-07-09","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in full on the earlier of (i) July 9, 2018 or (ii) the day prior to the Issuer's 2018 annual stockholder meeting."}],"balance_after":27300,"source":{"system":"sec-edgar","filing":"0001209191-17-044827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117044827/doc4.xml","form_type":"4"}},{"id":4542721,"issuer":{"id":180876,"kind":"organization","name":"EndoChoice Holdings, Inc.","symbol":"GI"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2016-11-23T15:22:34.000Z","date":"2016-11-22","kind":"disposition_to_issuer","acquired":false,"shares":47446,"price":8,"value":379568.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the \"Merger\"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001623919-16-000100","document":"wf-form4_147991453354204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162391916000100/wf-form4_147991453354204.xml","form_type":"4"}},{"id":4542720,"issuer":{"id":180876,"kind":"organization","name":"EndoChoice Holdings, Inc.","symbol":"GI"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2016-11-23T15:22:34.000Z","date":"2016-11-22","kind":"disposition_to_issuer","acquired":false,"shares":8423,"price":8,"value":67384.0,"ownership":{"direct":false,"nature":"By Front Foot Trust"},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the \"Merger\"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares previously directly held by the reporting person were transferred to Front Foot Trust on September 1, 2016.  Front Foot Trust is owned directly and equally by the reporting person and Deborah Legome Huennekens and may therefore be deemed to beneficially own the shares owned by Front Foot Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001623919-16-000100","document":"wf-form4_147991453354204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162391916000100/wf-form4_147991453354204.xml","form_type":"4"}},{"id":4542719,"issuer":{"id":180876,"kind":"organization","name":"EndoChoice Holdings, Inc.","symbol":"GI"},"owners":[{"id":34767,"kind":"person","name":"Huennekens R Scott","position":1,"cik":"0001365493","reported_name":"Huennekens R Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2016-11-23T15:22:34.000Z","date":"2016-11-22","kind":"disposition_to_issuer","acquired":false,"shares":26666,"price":8,"value":213328.0,"ownership":{"direct":false,"nature":"By Saol Capital LLC"},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the \"Merger\"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Saol Capital LLC is owned equally by The Huennekens Family Trust dated June 14, 2007 and The Kieran and Mary Ellen Gallahue Revocable Family Trust dated January 24, 2004, as amended, which hold voting and dispositive power with respect thereto. The Huennekens Family Trust dated June 14, 2007 is owned directly and equally by the reporting person and Deborah Legome Huennekens. The Kieran and Mary Ellen Gallahue Revocable Trust is owned directly and equally by Kieran Thomas Gallahue and Mary Ellen Gallahue. By virtue of the relationships described in this footnote, the entities and individuals described herein may be deemed to beneficially own the shares owned by Saol Capital."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001623919-16-000100","document":"wf-form4_147991453354204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365493/000162391916000100/wf-form4_147991453354204.xml","form_type":"4"}}]}